Medical Device Market & Industry Briefs, October 2012
Brief summaries of recent medtech market and industry developments. This month we cover Medtronic’s acquisition of Kanghui, Greatbatch’s new R&D center in Singapore, the outlook for the ICD/CRT market, and Cook Medical’s newly launched ENT unit.
You may also be interested in...
The prospective medical device tax, the continuing decline of venture investing, pricing challenges, austerity measures in Europe, and other headwinds continued to push against the medtech industry in 2012. But emerging clinical and geographic markets, along with an active M&A market, are providing the industry with some momentum going into 2013.
Evidence – along with caution – continues to gather on the benefits of implantable cardioverter defibrillators to an expanding patient population.
In revised practice guidelines released Sept. 10, the American Heart Association, the Heart Rhythm Society and the American College of Cardiology Foundation say new evidence shows that many patients with mild heart failure can benefit from cardiac resynchronization devices.